Quince Therapeutics regains Nasdaq minimum bid price compliance

Quince Therapeutics, Inc.

Nasdaq notified Quince on Dec 4, 2023 of non-compliance due to bid price below $1.00 for 30 consecutive days.
On Dec 29, 2023, Nasdaq confirmed compliance after closing bid price ≥ $1.00 for 13 consecutive business days.
The matter is closed; Quince remains listed on the Nasdaq Global Select Market.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.